CPPF, A Novel Microtubule Targeting Anticancer Agent, Inhibits the Growth of a Wide Variety of Cancers

In the past, several microtubule targeting agents (MTAs) have been developed into successful anticancer drugs. However, the usage of these drugs has been limited by the acquisition of drug resistance in many cancers. Therefore, there is a constant demand for the development of new therapeutic drugs....

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ho Jin, Park, Chanmi, Hwang, Joonsung, N.R., Thimmegowda, Kim, Sun-Ok, Han, Junyeol, Woo, Minsik, B, Shwetha, Ryoo, In-Ja, Lee, Kyung Ho, Cha-Molstad, Hyunjoo, Kwon, Yong Tae, Kim, Bo Yeon, Soung, Nak-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370279/
https://www.ncbi.nlm.nih.gov/pubmed/32645923
http://dx.doi.org/10.3390/ijms21134800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370279/
https://www.ncbi.nlm.nih.gov/pubmed/32645923
http://dx.doi.org/10.3390/ijms21134800

Ejemplares similares